All posts by imreal

Industry: Healthcare

The Dentists of Smile Glen Ellyn Provide Full Mouth Teeth Tomorrow Dental Implants in Glen Ellyn, IL

Leave a comment


Drs. Jessica and Thomas Gibbs, Dentists in Glen Ellyn, IL

Dentists, Drs. Jessica and Thomas Gibbs, Provide Teeth Tomorrow to Glen Ellyn, IL

Prettau Zirconia is the only dental implant material with a verified five-year, 100 percent success rate.


Glen Ellyn, IL (PRWEB)

Drs. Thomas and Jessica Gibbs, dentists in Glen Ellyn, IL, now offer the new, leading full arch dental implant solution, Teeth Tomorrow®. Many patients with numerous missing teeth or ill-fitting dentures consider dental implants as the ideal solution for improved aesthetics, function, and overall health. Unlike the latest trend of same-day dental implants, Teeth Tomorrow focuses on providing proper gum healing and creating strong, long-lasting dental bridges.

Unlike traditional teeth-in-a-day procedures, with Teeth Tomorrow, patients can heal overnight allowing the swelling from surgery to decrease. When they return the next day, patients are given an immediately functional dental appliance. These appliances are made in a dental lab overnight, creating a more refined dental bridge than those made in a dental office.

The final Teeth Tomorrow dental appliance is crafted from a solid block of Prettau® Zirconia, a unique, high-quality material that does not chip, crack, stain, or attract plaque. Prettau Zirconia is the only dental implant material with a verified five-year, 100 percent success rate. Custom-crafted, these zirconia bridges are made to each patient’s individual specifications, improving function as well as complementing facial aesthetics. The Teeth Tomorrow dental implant solution is now the preferred full arch treatment that Drs. Thomas and Jessica Gibbs recommend.

The dentists at Smile Glen Ellyn use the latest technology to predict the best placement for each dental implant. With their cone beam 3D CT scanner, Drs. Thomas and Jessica Gibbs measure the quantity and quality of the jawbone to get a precise analysis, within 100 microns, of where each dental implant should be placed. They complete tooth extractions when necessary and offer nitrous oxide, oral sedation, and IV sedation to help each patient feel comfortable. In addition to dental implants, the dentists at Smile Glen Ellyn also offer WaterLase® laser dentistry, Invisalign®, and custom cosmetic dentistry treatments.

Patients with severely damaged or missing teeth who are looking for a dentist in Glen Ellyn, IL can connect with Drs. Thomas and Jessica Gibbs for a Teeth Tomorrow consultation by calling 630-858-8800 or visiting http://www.smileglenellyn.com.

About the Dentists

Smile Glen Ellyn has been offering the community of Glen Ellyn, IL, comprehensive dental care for over 30 years. Drs. Thomas and Jessica Gibbs provide leading-edge care in their family-friendly office, providing a range of services from general and preventative care, to restorative and cosmetic dentistry. The team specializes in gentle dentistry through sedation options, including offering advanced IV sedation for those with extreme dental anxiety. The practice is proud to improve the oral health and aesthetics of patients’ smiles in a comforting atmosphere. To learn more about Drs. Thomas and Jessica Gibbs, their team or the services they offer, visit http://www.smileglenellyn.com or call 630-858-8800 to schedule a one-on-one consultation.

Share article on social media or email:

Health

The Dentists at Clearwater Dental Associates Open Second Dental Practice Location in Dunedin, FL

Leave a comment


The Dentists of Clearwater Dental Associates, Serving Clearwater and Dunedin, FL

Clearwater Dental Associates Opens New Practice in Dunedin, FL

The most rewarding part of dentistry, to me, is helping people and solving their problems.


DUNEDIN, Fla. (PRWEB)

Patients seeking a dentist in Dunedin, FL can now receive modern care at Clearwater Dental Associates’ newest practice. The new practice is located in Dunedin and offers leading dental technology, as well as the most cutting-edge treatments in dentistry. These treatments include gum disease care, Invisalign® and sleep apnea treatment, complete with soothing sedation dentistry. Dentists, Drs. Matthew Burton and William Spencer, travel between the new Dunedin practice and the Clearwater, FL location to provide this state-of-the-art care.

The dentists at Clearwater Dental Associates believe in comprehensive dental care backed by cutting-edge technology. The new practice offers leading care for gum disease, including laser dentistry, Invisalign clear aligners to straighten teeth, crowns and bridges, porcelain veneers and care for patients suffering from sleep apnea. Those seeking general dentistry can also receive their routine hygiene cleanings and checkups at this new facility.

Dr. Spencer is extensively trained in sedation dentistry from the University of Texas. With that training, the new Dunedin practice offers a variety of sedation options for those who experience dental anxiety or are worried about discomfort. Patients seeking sedation dentistry can receive:

  • Nitrous oxide

  • Oral sedation

  • IV sedation

  • Local anesthetic


Clearwater Dental Associates also has a large office located in Clearwater, FL. This 17-seat facility offers the same comprehensive dental care, along with the ability to serve those in need of dental implants. The team can perform single, multiple and full mouth dental implant treatments, with the implants made in-house using advanced milling equipment and 3D printers. This customized treatment can be combined with sedation dentistry to give patients comfortable and comprehensive care, even for complex cases.

“The most rewarding part of dentistry, to me, is helping people and solving their problems,” says Dr. Burton. “That can include people going through terrible pain or who don’t like the look of their smile. Whatever the case is, we can change that smile to make them go from not wanting to smile, to feeling confident to show it off.”

Patients seeking a dentist in Dunedin, FL can now get modern care from the experienced team at Clearwater Dental Associates. To schedule an appointment, the Dunedin office can be reached by calling 727-734-3321 or by visiting the website at http://www.cdadental.com.

About the Dentists

Clearwater Dental Associates is a team of leading dentists serving patients in the Clearwater area for over 30 years. Drs. Matthew Burton, Keith Kiskaddon, Nolan Allen, Maria Hernandez, James Hayslett, and William Spencer offer comprehensive services at two locations, with offices in Clearwater and Dunedin, FL. The Clearwater facility alone holds 17 seats and over 20 team members. Clearwater Dental Associates provides the latest in dental treatments and technology, including full mouth dental implants, Invisalign®, sedation dentistry, general dental care and an in-house lab. A patient-centered practice, each doctor and team member is dedicated to patient comfort and education. To learn more about Clearwater Dental Associates or to schedule a personalized appointment, call 727-797-8800 for the Clearwater, FL location, 727-734-3321 for the Dunedin, FL office or visit http://www.cdadental.com.

Share article on social media or email:

Business: Executives

Latin Touch Agency Opens New Location in Newton, MA

Leave a comment


The new golden rule

“Success means making meaningful work that promotes inclusivity and community” Alexandra Arrivillaga


NEWTON, Mass. (PRWEB)

Today, LatinTouch Agency announces that it has opened its doors with an office location in Newton, Mass. Operated by communications and management consultant expert proudly Latina Alexandra Arrivillaga, the company provides business consultation to public, private and non-profit organizations.

Latin Touch Agency specializes in advisory services with strong community ties. Its services include:

  • Business Process Services to improve performance, enhance productivity and drive growth initiatives

  • Organizational Change Management to help executives with strategic and transformational challenges

  • Customer Relationship Management to build strong relationships with customers.

“Latin Touch Agency, Means making meaningful work that promotes inclusivity and community,” Arrivillaga said. Arrivillaga served as CEO of her company, Lock It Up Security, LLC, from 2009 until it was sold in 2015 for an undisclosed amount. As CEO, she brought the company from humble beginnings to implementing security solutions for Fortune 500 companies.

In the tradition of her former startup, Latin Touch Agency is off to an auspicious start and already gaining popularity. It is currently engaging 60,193 people and has garnered more than 10,000 likes on its Facebook page in less than a week.

This recognition is not only in response to Arrivillaga’s excellent reputation in the business world but also a response to her strong community ties and continuous involvement in the Latin communities.

The company’s new offices are located at 280 Boylston Street, Newton, MA 02467.

For more information, visit Latin Touch Agency’s website at http://www.latintouchagency.com or call (774)285-6234

About Alexandra Arrivillaga

Arrivillaga is a proudly Latina communications professional and management consultant based in the greater Boston area.

She received her bachelor’s degree from Lesley University and her Master in Management from Cambridge College. She has completed doctorate work at Concord Law School as well as doctorate work in general business.

Arrivillaga proudly Latina maintains strong Boston ties and is heavily involved in the Latino Community. She has an excellent record in Latino and women empowerment and business development and is fluent in English and Spanish as well as conversational in Italian or Portuguese.

“Her new company is Latin Touch. Its namesake is in reference to Arrivillaga’s proudly latin heritage. She proudly embraces her latin heritage to create successful companies that promote inclusivity and community. The need of evolving influences to promote us the latin consumer, american, war veterans and community is still strongly needed. I experienced racism at a local private luxury gym in newton mass because, I am proudly Latin, more work is needed to promote us positively. My business will now and always represent “meaningful work that promotes inclusivity and community” Arrivillaga

Share article on social media or email:

Health

Canal Calem Periodontics Stabilizes Loose Dentures in Cherry Hill, NJ with Dental Implants

Leave a comment


Periodontists, Drs. Mario Canal and Ben Calem, and Their Staff at Canal Calem Periodontics, Serving Cherry Hill, NJ

Canal Calem Periodontics Secures Loose Dentures in Cherry Hill, NJ

Implant supported dentures are a way to get fixed or removable teeth for a patient utilizing implant therapy.


CHERRY HILL, N.J. (PRWEB)

Patients in Cherry Hill, NJ can find a solution to their loose dentures through the placement of dental implants at the respected Medford, NJ practice, Canal Calem Periodontics. Drs. Mario Canal and Ben Calem offer implant supported dentures to secure a denture prosthesis to as few as two dental implants placed within the jaw. These dental implants add security to the denture, preventing it from slipping, falling out or causing pain to the gums.

One of the lesser-known side effects of long-term denture wear is the eventual loss of jawbone volume. Without a tooth root or dental implant to stimulate bone growth, the jawbone will begin to deteriorate. This is often accelerated with the pressure dentures put on the bone. As bone loss occurs, facial shape changes and causes the denture to no longer fit properly, leading to a loose, uncomfortable fit. Patients must then have their denture adjusted or create a new one. By simply placing dental implants into the jawbone and attaching the denture to these implants, these concerns can be avoided.

“Implant supported dentures are a way to get fixed or removable teeth for a patient utilizing implant therapy,” says Dr. Canal. “An implant can be put in for a fixed tooth or for a removable tooth. This includes full arches of teeth.”

Dental implants are biocompatible titanium posts that are often considered to be the “gold standard” solution to replace missing teeth. When placed into the jaw to secure a denture, the implant post will mimic the function of a natural tooth root, stimulating the bone to prevent deterioration. A denture can be retrofit to attach to the implants, which hold the denture firmly in place. With implant supported dentures, there is virtually no risk of the denture shifting or moving. Plus, the denture rests comfortably on the implants, not the gums. Compared to traditional dentures, implant supported dentures offer many advantages, including:

  • Security within the jaw

  • A more natural bite

  • Preservation of the jawbone

  • Improved comfort to wear

  • A long-lasting tooth loss solution

Implant supported dentures can significantly improve quality of life, enhance comfort and offer improved oral function to denture wearers. Patients with loose dentures who are interested in receiving dental implants in Cherry Hill, NJ or surrounding areas are encouraged to contact Canal Calem Periodontics for a consultation. The practice can be reached online at http://www.canalcalemperio.com or at one of their two locations in Moorestown and Medford, NJ. To connect with the Moorestown location, call 856-439-1200. For the Medford office, call 609-953-3700.

About the Practice

Canal Calem Periodontics offers modern periodontal treatments for patients in Moorestown and Medford, NJ. Since 1993, Canal Calem Periodontics has been a resource in South Jersey for providing comprehensive periodontal and implant therapy. Working closely with the general dentist, Drs. Mario J. Canal and Ben Calem strive to improve their patients’ oral health and re-develop their dentition, where necessary. Both Drs. Canal and Calem are active in the community through their involvement with Donated Dental Services and The Holocaust Survivor’s Program. In addition, their strong belief in organized dentistry has led them both to serve as President of the Southern Dental Society. To learn more about the services they offer or to schedule a consultation at Canal Calem Periodontics visit http://www.canalcalemperio.com or call 609-534-5541 for the Medford, NJ office or 856-203-6588 for the Moorestown, NJ location.

Share article on social media or email:

Industry: Healthcare

NeoTract Designates Dr. Vi Hua as UroLift® Center of Excellence

Leave a comment


News Image

“We are pleased to recognize Dr. Vi Hua as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson


PLEASANTON, Calif. (PRWEB)

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Dr. Vi Hua MD Valley Urologic Associates in Goodyear, AZ has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Hua has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are pleased to recognize Dr. Vi Hua as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “This achievement has helped many patients experience durable, long-term relief from the burdensome symptoms of BPH while preserving sexual function*1,2.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Business: Insurance

Lombardi Associates Appoints New Specialty Supervisor Karen Blitz

Leave a comment


Karen Blitz

Karen is dedicated to helping injured workers get well and return to work


FAIRFIELD, N.J. (PRWEB)

Karen Blitz, RN, MS, BSN, CCM, PHN joins Lombardi Associates as Specialty Supervisor in January 2020. She has over 30 years’ experience in the workers compensation industry and has worked for a number of insurance companies including Chubb, Liberty and Zurich.

Karen began her career working on a medical-surgical floor as a staff nurse before moving onto Public Health Nursing. She holds a BS in Nursing and a MS in Health Care Administration and is certified as a Case Manager and Public Health Nurse.

In 1984, she worked as a Nurse Consultant at Fireman’s Fund where she performed telephonic and field nurse case management, job analyses, and oversight of vocational rehabilitation. She quickly moved into management where she acted as supervisor, manager, and director. She established and oversaw an entire medical case management department of telephonic and field case managers, policies and procedures, quality assurance, auditing processes and medical vendor/cost savings programs such as medical provider networks (MPN), pharmacy benefit management (PBM), early detection/analytics, utilization review (UR), and early intervention (EI)/triage programs. She also was involved in start-up home health agencies for corporations as a Director of Nursing while obtaining Medicare and MediCal (Medicaid) certification.

Karen’s expertise involves working as a liaison between injured workers, claims adjusters, medical providers, employers, shareholders and attorneys; she is dedicated to helping injured workers get well and return to work the quickest way possible at the best costs.

About Lombardi Associates

Lombardi Associates is a woman owned business and a national provider of case management, crisis management, vocational rehabilitation and cost management solutions for insurance carriers, third party administrators, attorneys and employers. Lombardi Associates supports the workers’ compensation, auto, disability and general liability insurance markets.

Share article on social media or email:

Business: Executives

NanoFUSE Biologics Names Renowned Surgeon Dr. Darren Lebl to Its Growing Scientific Advisory Board

Leave a comment


“We’re fortunate to have a NanoFUSE Scientific Advisory Board of the best spine and orthopedic surgeons who are at the forefront of biologics use. We are privileged to welcome Dr. Lebl as the latest member to our team.”


BOSTON (PRWEB)

NanoFUSE Biologics is pleased to announce the addition of Dr. Darren Lebl to its Scientific Advisory Board. NanoFUSE Biologics offers a biologically enhanced synthetic therapeutic, which is the only FDA-cleared bioactive glass and demineralized bone matrix (DBM) combined medical device.

President of NanoFUSE Biologics, Jake Lubinski, said, “We’re fortunate to have a NanoFUSE Scientific Advisory Board of the best spine and orthopedic surgeons who are at the forefront of biologics use. Dr. Lebl brings a wealth of prestigious and extensive experience with biologics and how those biologics are used to best care for patients. We are privileged to welcome Dr. Lebl as the latest member to our team.”

Dr Lebl noted, “I am honored to be part of the Scientific Advisory Board for NanoFUSE. Spine surgery continues to evolve toward less invasive techniques that require surgeons to have the latest in biologic technology like NanoFUSE to help us achieve fusion with consistently successful results”

Dr. Darren Lebl is an Associate Professor of spinal surgery specializing in minimally invasive surgery, the cervical spine, motion preserving spine procedures, and robotic computer guided navigation surgery. His practice at Hospital for Special Surgery in New York City involves a customized approach to each individual patient to help maximize quality of life and musculoskeletal health. He incorporates innovative procedures, newer and less invasive surgical techniques, and biologics into his practice

.

After obtaining a triple major in biochemistry & molecular biology, chemistry, and economics at The University of Chicago Dr. Lebl received his MD degree from Stanford. He completed his orthopedic residency at Harvard, a spine surgery fellowship at The Hospital for Special Surgery in New York City, and an MBA from Wharton. He pursued additional advanced spine surgery training in cervical spine disorders, occipitocervical disorders, and spinal deformity surgery with international leaders in the USA, China, Japan, Spain, and Germany.

About NanoFUSE Biologics

NanoFUSE is a biologically enhanced synthetic therapeutic that combines osteoinductive DBM with the osteostimulative properties of bioactive glass. NanoFUSE is the only FDA-cleared combination of DBM and bioactive glass and is indicated for use in general orthopedic applications. NanoFUSE Biologics is a KICVentures portfolio company and is distributed by SpineFrontier.

About KICVentures

KICVentures is a private investment holding company founded by Harvard-trained Orthopedic Surgeon & Professor Dr. Kingsley R. Chin, who brings unique experience at the intersection of medicine, business and information technology. KICVentures is equipped with a strong advantage in identifying niche healthcare opportunities and has a proven track-record of building the most disruptive spine technology portfolio, including AxioMed, NanoFUSE and SpineFrontier. It has headquarters in Boston, MA.

About Dr Darren Lebl

Dr. Lebl was the Editor-in-Chief of the Orthopedic Journal at Harvard Medical School and Academic Chief Resident at the Massachusetts General Hospital. He was later recognized as an “emerging leader” by the world’s oldest and most distinguished orthopedic association, the American Orthopedic Association, for his contributions to education and research. He has authored numerous peer-reviewed articles and book chapters on complication avoidance in spinal surgery, cervical spine disorders, minimally invasive procedures, and motion preserving spine procedures. Dr. Lebl was the director of both the Complex Cervical Spine Symposium and the Cervical Spine Motion Preservation Symposium at HSS. Dr. Lebl is a Fellow of the American Academy of Orthopedic Surgeons and an active member of distinguished societies such as the Cervical Spine Research Society, the North American Spine Society, and the Scoliosis Research Society.

Share article on social media or email:

Health

NeoTract Designates Dr. Patrick P. Daily as UroLift® Center of Excellence

Leave a comment


News Image

“This designation recognizes Dr. Patrick Daily as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson


PLEASANTON, Calif. (PRWEB)

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Dr. Patrick P. Daily, MD, Mississippi Urology Clinic, PLLC in Jackson, MS, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Daily has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Patrick Daily as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Science: Biology

Vici Health Sciences Expands Staff and Footprint in Maryland to Meet Customer Demands

Leave a comment


A FULL SERVICE PHARMACEUTICAL R&D COMPANY

We work hard to provide our clients innovative R&D solutions to bring their drugs to the market. Our clients want to develop high quality pharmaceutical drug products rapidly and clearly recognize the value we are able to provide.


ELKRIDGE, Md. (PRWEB)

Vici Health Sciences announces it is breaking ground in expanding its pharmaceutical product development lab in Maryland. Emphasis will be in expanding capabilities in both oral and parenteral dosage forms. With the increased size and expanded capabilities, Vici Health Sciences will be well positioned to meet the growing demand for its pharmaceutical formulation and analytical method development services. Founded in 2016 with the aim of rapidly developing drugs to meet acute and long-term market needs, Vici currently works with over 10 different pharmaceutical companies and continues to expand its client base. The current expansion is focused on improving capabilities in manufacturing GMP clinical supplies and increases Vici’s ability to handle additional clients simultaneously.

Dr Anish Dhanarajan, CEO and co-founder stated: “We work hard to provide our clients innovative R&D solutions to bring their drugs to the market. Our clients want to develop high quality pharmaceutical drug products rapidly and clearly recognize the value we are able to provide. This expansion will allow us to meet the growing demand for our services.”

About Vici Health Sciences LLC

Vici Health Sciences (Vici) is a U.S. based pharmaceutical research and development company. Vici is focused on providing innovative, flexible, high quality, and low-cost R&D services to small and mid-sized pharmaceutical companies that need to grow their product portfolio. Vici currently focuses on oral and injectable dosage forms and operates an R&D and GMP facility capable of developing formulations, analytical methods, and manufacturing phase 1/pilot clinical supplies.

Share article on social media or email:

health and fitness

A Growing Public Heath Movement That Can Save Thousands of Lives Each Year

Leave a comment


Call-Push-Shock logo

Call-Push-Shock social media campaign

By using consistent messaging about sudden cardiac arrest, we can save thousands of lives each year.”


PITTSBURGH (PRWEB)

Call-Push-Shock, a social media campaign designed to encourage bystander action in cases of out-of-hospital cardiac arrest, is becoming a national public health movement. Results of the initiative, co-sponsored by Parent Heart Watch and the Sudden Cardiac Arrest Foundation and grounded in research by global consumer research firm, StrataVerve, were presented at the Cardiac Arrest Survival Summit in Seattle earlier this month.

Sudden cardiac arrest (SCA) is a national public health crisis. About 1,000 people suffer SCA outside hospital settings every day in the U.S. On average, only in one in 10 victims survives. Those who survive invariably received immediate CPR and quick treatment with a defibrillator.

The Call-Push-Shock initiative was developed in response to an appeal from the Institute of Medicine (IOM), now the National Academy of Medicine, urging collaboration among stakeholders to help improve survival from sudden cardiac arrest. The purpose of the campaign is to motivate bystanders to call 911, give CPR, and use AEDs (automated external defibrillators) to help save lives threatened by sudden cardiac arrest. One of the ways to help improve survival, according to the IOM, is for organizations to speak in one voice with consistent messaging aimed at increasing rates of bystander intervention with CPR and use of AEDs.

The Call-Push-Shock campaign is grounded in research conducted for the Sudden Cardiac Arrest Foundation by global consumer research firm, StrataVerve,

focused on public awareness, understanding, and messaging that resonates with laypersons. “We found that when consumer research is evaluated in comparison with data from CARES (the Cardiac Arrest Registry to Enhance Survival), about 14% more lives could be saved each year if bystanders intervened right away,” said Jennifer Chap, principal at StrataVerve.

The following definition was tested among consumers and is recommended for all to use: “Sudden cardiac arrest is a life-threatening emergency that occurs when the heart suddenly stops beating. It strikes people of all ages who may seem to be healthy, even children and teens. When SCA happens, the person collapses and doesn’t respond or breathe normally. They may gasp or shake as if having a seizure. SCA leads to death in minutes if the person doesn’t get help right away. Survival depends on people nearby calling 911, starting CPR, and using an AED (if available) as soon as possible.”

The campaign was launched in June 2018. Assets include a landing page, Call-Push-Shock.org, and a user-friendly toolkit that features a simple explanation of SCA tested among laypersons, an infographic, images created for Facebook and Twitter, videos of “man-in-the street” interviews, and a social media calendar with suggested posts. Assets are available in English and Spanish.

By October 2018, there were 20 co-partners. By early December 2019, there were 35 co-partners. By the end of December, another 15 organizations had expressed interest in joining the campaign.

“We are thrilled that so many stakeholders are joining the Call-Push-Shock movement,” said Mary Newman, Sudden Cardiac Arrest Foundation president. “We believe that if we speak in one voice across all of our platforms, we can dramatically improve survival from sudden cardiac arrest.”

Martha Lopez-Anderson, Parent Heart Watch executive director, agrees. “We welcome other organizations to join the Call-Push-Shock movement. By using consistent messaging about sudden cardiac arrest, we can save thousands of lives each year.”

To join the national movement, reach out to: contact@callpushshock.org.

About the Sudden Cardiac Arrest Foundation

The Sudden Cardiac Arrest Foundation is a national community benefit 501(c)(3) organization dedicated to raising awareness about sudden cardiac arrest and saving lives. Bystander intervention can triple the chance of survival and we work to promote this message.

About Parent Heart Watch

Parent Heart Watch (PHW) is the only national organization focused solely on protecting youth from sudden cardiac arrest and preventable sudden cardiac death. PHW leads and empowers others by educating and advocating for change. PHW is comprised of parents and who have been personally touched by sudden cardiac arrest or sudden cardiac death and other passionate advocates who put their time and effort into preventing SCA/SCD in the young throughout their communities.

About StrataVerve

StrataVerve is a strategic marketing and research firm with expertise in consumer insights, product development and brand strategy across multiple categories. The StrataVerve difference is an integrated, analytic decision-driven approach that turns research findings into consumer action.

Share article on social media or email: